Scientists find that removing IGF2BP3 selectively targets cancer cells while leaving healthy cells alone.
Denise Heady | July 28, 2021 | UCLA
Other study authors included Jaspal Bassi, Neha Nibber, Tasha Lin, Jayanth Palanichamy, Amit Jaiswal, May Paing, and Jennifer King, all of UCLA; Julia Philipp, Jolene Draper, Sol Katzman and Jeremy Sanford of UC Santa Cruz; and Oscar Silva of Stanford University. The work was supported in part by the National Institutes of Health.
Read ‘Eliminating RNA-binding protein improves survival in aggressive leukemia‘